# AGONOX, INC.: Enriching and expanding  tumor-reactive CD8 T-cells to treat breast cancer

**Lab Budget Score:** 55/100

| Field | Value |
|---|---|
| Organization | AGONOX, INC. |
| Location | PORTLAND, OR |
| Project | Enriching and expanding  tumor-reactive CD8 T-cells to treat breast cancer |
| Project number | 1R44CA314796-01 |
| Mechanism | R44 |
| Institute | National Cancer Institute |
| Award | $977,639 |
| Awarded | 2026-09-17 |
| Project period | 2026-09-18 to 2028-08-31 |
| UEI | YNKLZNLCCE85 |

## Why this score
- Award of $400K or more.
- Research or center grant: supplies, instruments and services budget.

Source: NIH RePORTER (newly awarded projects) (https://reporter.nih.gov/project-details/11408886). Last refreshed: 2026-11-03T18:16:24.961Z.
Award data comes from NIH RePORTER and may be revised by NIH. Organization-level only; investigator names and contacts are not included. Informational only.